Abstract
Efficacy of EP102 (Oral Fospropofol) for the Acute Treatment of Migraine in an Open-label Proof-of-concept Trial: Effect of Time to Treatment (P6-12.009)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have